128
Participants
Start Date
December 13, 2024
Primary Completion Date
July 31, 2026
Study Completion Date
December 31, 2026
PMN310
A humanized immunoglobulin G1 (IgG1) monoclonal antibody
Placebo
0.9% NaCl 100 mL
RECRUITING
Alzheimer's Disease Research Center, Albany
RECRUITING
Keystone Clinical Studies, LLC, Plymouth Meeting
RECRUITING
Flourish Research, Matthews
RECRUITING
CenExel iResearch, LLC, Decatur
RECRUITING
Columbus Memory Center, LLC, Columbus
RECRUITING
Charter Research, The Villages
RECRUITING
Conquest Research, LLC, Winter Park
RECRUITING
Charter Research, Orlando
RECRUITING
Finlay Medical Research, Miami
RECRUITING
Gonzalez MD and Aswad MD Health Services, Optimus U Corp, Miami
RECRUITING
Alzheimer's Research and Treatment Center, Wellington
RECRUITING
Quantum Laboratories, Deerfield Beach
RECRUITING
Brain Matters Research, Delray Beach
RECRUITING
JEM Research Institute, Atlantis
RECRUITING
Renstar Medical Research, Ocala
RECRUITING
Alzheimer's Research and Treatment Center, Stuart
RECRUITING
Neuro Behavioral Clinical Research, Inc., North Canton
RECRUITING
Kerwin Medical Center, Dallas
RECRUITING
Healthy Brain Research, Long Beach
RECRUITING
Irvine Center for Clinical Research, Irvine
RECRUITING
Headlands Eastern MA LLC, Plymouth
RECRUITING
Advanced Memory Research Institute of NJ, Toms River
Lead Sponsor
ProMis Neurosciences, Inc
INDUSTRY